Pulmonale Hypertonie - Versionsgeschichte

https://ddn.pluspedia.org/w/index.php?action=history&feed=atom&title=Pulmonale_Hypertonie Pulmonale Hypertonie - Versionsgeschichte 2026-09-10T06:31:26Z Versionsgeschichte dieser Seite in PlusPedia MediaWiki 1.43.3 https://ddn.pluspedia.org/w/index.php?title=Pulmonale_Hypertonie&diff=43958&oldid=prev Ossip Groth am 15. April 2010 um 17:23 Uhr 2010-04-15T17:23:24Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="de"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 15. April 2010, 17:23 Uhr</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l2">Zeile 2:</td> <td colspan="2" class="diff-lineno">Zeile 2:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{| class="wikitable" |</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{| class="wikitable" |</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |<ref name="PMID11015616">Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. Physiol Rev 80(4):1337-72 (2000) PMID 11015616 </ref><ref name="PMID16103472">Evaluation and management of the patient with pulmonary arterial hypertension. Ann Intern Med 143(4):282-92 (2005) PMID 16103472 </ref><ref name="PMID18381346">The management of pulmonary hypertension in children. Arch Dis Child 93(7):620-5 (2008) PMID 18381346 </ref><ref name="PMID16320330">Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 52(12):3792-800 (2005) PMID 16320330 </ref><ref name="PMID12209501">Pulmonary hypertension in autoimmune rheumatic diseases: where are we now? Arthritis Rheum 46(8):1997-2009 (2002) PMID 12209501 </ref><ref name="PMID14180523">PRIMARY PULMONARY HYPERTENSION: A REVIEW, AND REPORT OF FIVE CASES. Can Med Assoc J 91():145-53 (1964) PMID 14180523 </ref><ref name="PMID19059957">Molecular mechanisms of pulmonary arterial hypertension: role of mutations in the bone morphogenetic protein type II receptor. Chest 134(6):1271-7 (2008) PMID 19059957 </ref><ref name="PMID18641107">ECG monitoring of treatment response in pulmonary arterial hypertension patients. Chest 134(6):1250-7 (2008) PMID 18641107 </ref><ref name="PMID18321898">Estimation of mean pulmonary artery pressure: simpler than expected. Chest 133(3):592-3 (2008) PMID 18321898 </ref><ref name="PMID15888866">Pulmonary arterial hypertension: the key role of echocardiography. Chest 127(5):1836-43 (2005) PMID 15888866 </ref><ref name="PMID15249495">Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126(1 Suppl):63S-71S (2004) PMID 15249495 </ref><ref name="PMID15249494">Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126(1 Suppl):35S-62S (2004) PMID 15249494 </ref><ref name="PMID15249493">Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126(1 Suppl):14S-34S (2004) PMID 15249493 </ref><ref name="PMID6365477">Pulmonary hypertensive diseases. Chest 85(3):397-405 (1984) PMID 6365477 </ref><ref name="PMID4810679">A problem in pulmonary hypertension. 2. The final course and autopsy findings. A clinicopathologic conference from the Division of Pulmonary Diseases, Hahnemann Medical College and Hospital, Philadelphia. Chest 65(2):192-7 (1974) PMID 4810679 </ref><ref name="PMID5099816">A reconsideration of the origins of pulmonary hypertension. Chest 59(1):82-94 (1971) PMID 5099816 </ref><ref name="PMID18614776">Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure? Clin J Am Soc Nephrol 3(5):1232-7 (2008) PMID 18614776 </ref><ref name="PMID18669790">Biomarkers in pulmonary hypertension. Eur Respir J 32(2):503-12 (2008) PMID 18669790 </ref><ref name="PMID18515559">Pulmonary hypertension in interstitial lung disease. Eur Respir J 31(6):1357-67 (2008) PMID 18515559 </ref><ref name="PMID18378784">Prostacyclin therapies for the treatment of pulmonary arterial hypertension. Eur Respir J 31(4):891-901 (2008) PMID 18378784 </ref><ref name="PMID18238950">Endothelin receptor antagonists in pulmonary arterial hypertension. Eur Respir J 31(2):407-15 (2008) PMID 18238950 </ref><ref name="PMID18238945">Pulmonary hypertension: basic concepts and practical management. Eur Respir J 31(2):236-7 (2008) PMID 18238945 </ref><ref name="PMID17074918">Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review. Eur Respir J 28(5):999-1004 (2006) PMID 17074918 </ref><ref name="PMID15802353">Noninvasive assessment and monitoring of the pulmonary circulation. Eur Respir J 25(4):758-66 (2005) PMID 15802353 </ref><ref name="PMID15083767">Chronic thromboembolic pulmonary hypertension. Eur Respir J 23(4):637-48 (2004) PMID 15083767 </ref><ref name="PMID12570125">Pulmonary arterial hypertension in children. Eur Respir J 21(1):155-76 (2003) PMID 12570125 </ref><ref name="PMID12503718">Pathobiology of pulmonary arterial hypertension. Eur Respir J 20(6):1559-72 (2002) PMID 12503718 </ref><ref name="PMID12449189">Haemodynamic evaluation of pulmonary hypertension. Eur Respir J 20(5):1314-31 (2002) PMID 12449189 </ref><ref name="PMID12412701">The new clinical trials on pharmacological treatment in pulmonary arterial hypertension. Eur Respir J 20(4):1037-49 (2002) PMID 12412701 </ref><ref name="PMID11936539">Pulmonary hypertension in collagen vascular disease. Eur Respir J 19(3):571-6 (2002) PMID 11936539 </ref><ref name="PMID10624750">Severe pulmonary hypertensive diseases: a perspective. Eur Respir J 14(6):1246-50 (1999) PMID 10624750 </ref><ref name="PMID8947091">Medical management of primary pulmonary hypertension. Eur Respir J 9(11):2401-9 (1996) PMID 8947091 </ref><ref name="PMID8666110">Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension. Eur Respir J 8(12):2129-38 (1995) PMID 8666110 </ref><ref name="PMID8575567">More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited. Eur Respir J 8(9):1445-9 (1995) PMID 8575567 </ref><ref name="PMID8143814">Medical treatment of pulmonary hypertension in chronic lung disease. Eur Respir J 7(1):148-52 (1994) PMID 8143814 </ref><ref name="PMID10801140">Diagnosis and treatment of pulmonary hypertension associated with collagen diseases. Intern Med 39(4):280-2 (2000) PMID 10801140 </ref><ref name="PMID14509142">Pulmonary arterial hypertension--the primary pulmonary hypertension syndromes. Isr Med Assoc J 5(4):298-303 (2003) PMID 14509142 </ref><ref name="PMID18596905">Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 118(7):2372-9 (2008) PMID 18596905 </ref><ref name="PMID19567712">Wide variation in clinicians' assessment of New York Heart Association/World Health Organization functional class in patients with pulmonary arterial hypertension. Mayo Clin Proc 84(7):586-92 (2009) PMID 19567712 </ref><ref name="PMID17352370">Pulmonary hypertension in patients with interstitial lung diseases. Mayo Clin Proc 82(3):342-50 (2007) PMID 17352370 </ref><ref name="PMID11484688">Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. N Engl J Med 345(5):319-24 (2001) PMID 11484688 </ref><ref name="PMID19825167">Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation. Respir Res 10():95 (2009) PMID 19825167 </ref><ref name="PMID17629802">Prognosis, screening, early detection and differentiation of arterial pulmonary hypertension. Swiss Med Wkly 137(23-24):331-6 (2007) PMID 17629802 </ref><ref name="PMID17370143">Update on therapies for pulmonary hypertension. Swiss Med Wkly 137(5-6):73-82 (2007) PMID 17370143 </ref><ref name="PMID16947087">Surgical treatment of chronic thromboembolic pulmonary hypertension. Swiss Med Wkly 136(31-32):491-7 (2006) PMID 16947087 </ref><ref name="PMID12644956">Pulmonary hypertension. Swiss Med Wkly 133(7-8):103-10 (2003) PMID 12644956 </ref><ref name="PMID10567632">Primary pulmonary hypertension. Thorax 54(12):1107-18 (1999) PMID 10567632 </ref><ref name="PMID18420094">Pulmonary arterial hypertension. J Am Coll Cardiol 51(16):1527-38 (2008) PMID 18420094 </ref><ref name="PMID15194183">Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):81S-88S (2004) PMID 15194183 </ref><ref name="PMID15194182">Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):73S-80S (2004) PMID 15194182 </ref><ref name="PMID15194181">Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):68S-72S (2004) PMID 15194181 </ref><ref name="PMID15194180">Endothelin receptor antagonists in pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):62S-67S (2004) PMID 15194180 </ref><ref name="PMID15194179">Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):56S-61S (2004) PMID 15194179 </ref><ref name="PMID15194178">End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives. J Am Coll Cardiol 43(12 Suppl S):48S-55S (2004) PMID 15194178 </ref><ref name="PMID15194177">Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):40S-47S (2004) PMID 15194177 </ref><ref name="PMID15194176">Genetic basis of pulmonary arterial hypertension: current understanding and future directions. J Am Coll Cardiol 43(12 Suppl S):33S-39S (2004) PMID 15194176 </ref><ref name="PMID15194175">Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 43(12 Suppl S):25S-32S (2004) PMID 15194175 </ref><ref name="PMID15194174">Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):13S-24S (2004) PMID 15194174 </ref><ref name="PMID15194173">Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43(12 Suppl S):5S-12S (2004) PMID 15194173 </ref></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |<ref name="PMID11015616">Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. Physiol Rev 80(4):1337-72 (2000) PMID 11015616 </ref><ref name="PMID16103472">Evaluation and management of the patient with pulmonary arterial hypertension. Ann Intern Med 143(4):282-92 (2005) PMID 16103472 </ref><ref name="PMID18381346">The management of pulmonary hypertension in children. Arch Dis Child 93(7):620-5 (2008) PMID 18381346 </ref><ref name="PMID16320330">Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 52(12):3792-800 (2005) PMID 16320330 </ref><ref name="PMID12209501">Pulmonary hypertension in autoimmune rheumatic diseases: where are we now? Arthritis Rheum 46(8):1997-2009 (2002) PMID 12209501 </ref><ref name="PMID14180523">PRIMARY PULMONARY HYPERTENSION: A REVIEW, AND REPORT OF FIVE CASES. Can Med Assoc J 91():145-53 (1964) PMID 14180523 </ref><ref name="PMID19059957">Molecular mechanisms of pulmonary arterial hypertension: role of mutations in the bone morphogenetic protein type II receptor. Chest 134(6):1271-7 (2008) PMID 19059957 </ref><ref name="PMID18641107">ECG monitoring of treatment response in pulmonary arterial hypertension patients. Chest 134(6):1250-7 (2008) PMID 18641107 </ref><ref name="PMID18321898">Estimation of mean pulmonary artery pressure: simpler than expected. Chest 133(3):592-3 (2008) PMID 18321898 </ref><ref name="PMID15888866">Pulmonary arterial hypertension: the key role of echocardiography. Chest 127(5):1836-43 (2005) PMID 15888866 </ref><ref name="PMID15249495">Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126(1 Suppl):63S-71S (2004) PMID 15249495 </ref><ref name="PMID15249494">Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126(1 Suppl):35S-62S (2004) PMID 15249494 </ref><ref name="PMID15249493">Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126(1 Suppl):14S-34S (2004) PMID 15249493 </ref><ref name="PMID6365477">Pulmonary hypertensive diseases. Chest 85(3):397-405 (1984) PMID 6365477 </ref><ref name="PMID4810679">A problem in pulmonary hypertension. 2. The final course and autopsy findings. A clinicopathologic conference from the Division of Pulmonary Diseases, Hahnemann Medical College and Hospital, Philadelphia. Chest 65(2):192-7 (1974) PMID 4810679 </ref><ref name="PMID5099816">A reconsideration of the origins of pulmonary hypertension. Chest 59(1):82-94 (1971) PMID 5099816 </ref><ref name="PMID18614776">Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure? Clin J Am Soc Nephrol 3(5):1232-7 (2008) PMID 18614776 </ref><ref name="PMID18669790">Biomarkers in pulmonary hypertension. Eur Respir J 32(2):503-12 (2008) PMID 18669790 </ref><ref name="PMID18515559">Pulmonary hypertension in interstitial lung disease. Eur Respir J 31(6):1357-67 (2008) PMID 18515559 </ref><ref name="PMID18378784">Prostacyclin therapies for the treatment of pulmonary arterial hypertension. Eur Respir J 31(4):891-901 (2008) PMID 18378784 </ref><ref name="PMID18238950">Endothelin receptor antagonists in pulmonary arterial hypertension. Eur Respir J 31(2):407-15 (2008) PMID 18238950 </ref><ref name="PMID18238945">Pulmonary hypertension: basic concepts and practical management. Eur Respir J 31(2):236-7 (2008) PMID 18238945 </ref><ref name="PMID17074918">Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review. Eur Respir J 28(5):999-1004 (2006) PMID 17074918 </ref><ref name="PMID15802353">Noninvasive assessment and monitoring of the pulmonary circulation. Eur Respir J 25(4):758-66 (2005) PMID 15802353 </ref><ref name="PMID15083767">Chronic thromboembolic pulmonary hypertension. Eur Respir J 23(4):637-48 (2004) PMID 15083767 </ref><ref name="PMID12570125">Pulmonary arterial hypertension in children. Eur Respir J 21(1):155-76 (2003) PMID 12570125 </ref><ref name="PMID12503718">Pathobiology of pulmonary arterial hypertension. Eur Respir J 20(6):1559-72 (2002) PMID 12503718 </ref><ref name="PMID12449189">Haemodynamic evaluation of pulmonary hypertension. Eur Respir J 20(5):1314-31 (2002) PMID 12449189 </ref><ref name="PMID12412701">The new clinical trials on pharmacological treatment in pulmonary arterial hypertension. Eur Respir J 20(4):1037-49 (2002) PMID 12412701 </ref><ref name="PMID11936539">Pulmonary hypertension in collagen vascular disease. Eur Respir J 19(3):571-6 (2002) PMID 11936539 </ref><ref name="PMID10624750">Severe pulmonary hypertensive diseases: a perspective. Eur Respir J 14(6):1246-50 (1999) PMID 10624750 </ref><ref name="PMID8947091">Medical management of primary pulmonary hypertension. Eur Respir J 9(11):2401-9 (1996) PMID 8947091 </ref><ref name="PMID8666110">Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension. Eur Respir J 8(12):2129-38 (1995) PMID 8666110 </ref><ref name="PMID8575567">More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited. Eur Respir J 8(9):1445-9 (1995) PMID 8575567 </ref><ref name="PMID8143814">Medical treatment of pulmonary hypertension in chronic lung disease. Eur Respir J 7(1):148-52 (1994) PMID 8143814 </ref><ref name="PMID10801140">Diagnosis and treatment of pulmonary hypertension associated with collagen diseases. Intern Med 39(4):280-2 (2000) PMID 10801140 </ref><ref name="PMID14509142">Pulmonary arterial hypertension--the primary pulmonary hypertension syndromes. Isr Med Assoc J 5(4):298-303 (2003) PMID 14509142 </ref><ref name="PMID18596905">Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 118(7):2372-9 (2008) PMID 18596905 </ref><ref name="PMID19567712">Wide variation in clinicians' assessment of New York Heart Association/World Health Organization functional class in patients with pulmonary arterial hypertension. Mayo Clin Proc 84(7):586-92 (2009) PMID 19567712 </ref><ref name="PMID17352370">Pulmonary hypertension in patients with interstitial lung diseases. Mayo Clin Proc 82(3):342-50 (2007) PMID 17352370 </ref><ref name="PMID11484688">Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. N Engl J Med 345(5):319-24 (2001) PMID 11484688 </ref><ref name="PMID19825167">Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation. Respir Res 10():95 (2009) PMID 19825167 </ref><ref name="PMID17629802">Prognosis, screening, early detection and differentiation of arterial pulmonary hypertension. Swiss Med Wkly 137(23-24):331-6 (2007) PMID 17629802 </ref><ref name="PMID17370143">Update on therapies for pulmonary hypertension. Swiss Med Wkly 137(5-6):73-82 (2007) PMID 17370143 </ref><ref name="PMID16947087">Surgical treatment of chronic thromboembolic pulmonary hypertension. Swiss Med Wkly 136(31-32):491-7 (2006) PMID 16947087 </ref><ref name="PMID12644956">Pulmonary hypertension. Swiss Med Wkly 133(7-8):103-10 (2003) PMID 12644956 </ref><ref name="PMID10567632">Primary pulmonary hypertension. Thorax 54(12):1107-18 (1999) PMID 10567632 </ref><ref name="PMID18420094">Pulmonary arterial hypertension. J Am Coll Cardiol 51(16):1527-38 (2008) PMID 18420094 </ref><ref name="PMID15194183">Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):81S-88S (2004) PMID 15194183 </ref><ref name="PMID15194182">Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):73S-80S (2004) PMID 15194182 </ref><ref name="PMID15194181">Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):68S-72S (2004) PMID 15194181 </ref><ref name="PMID15194180">Endothelin receptor antagonists in pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):62S-67S (2004) PMID 15194180 </ref><ref name="PMID15194179">Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):56S-61S (2004) PMID 15194179 </ref><ref name="PMID15194178">End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives. J Am Coll Cardiol 43(12 Suppl S):48S-55S (2004) PMID 15194178 </ref><ref name="PMID15194177">Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):40S-47S (2004) PMID 15194177 </ref><ref name="PMID15194176">Genetic basis of pulmonary arterial hypertension: current understanding and future directions. J Am Coll Cardiol 43(12 Suppl S):33S-39S (2004) PMID 15194176 </ref><ref name="PMID15194175">Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 43(12 Suppl S):25S-32S (2004) PMID 15194175 </ref><ref name="PMID15194174">Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):13S-24S (2004) PMID 15194174 </ref><ref name="PMID15194173">Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43(12 Suppl S):5S-12S (2004) PMID 15194173 </ref><ins style="font-weight: bold; text-decoration: none;"><ref name="PMID17416597">Pulmonary arterial hypertension: a disease of tethers, SNAREs and SNAPs? Am J Physiol Heart Circ Physiol 293(1):H77-85 (2007) PMID 17416597 </ref><ref name="PMID17601794">The hyperproliferative endothelial cell phenotype in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 293(3):L546-7 (2007) PMID 17601794 </ref><ref name="PMID16698850">Mediators and modulators of pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 291(4):L547-58 (2006) PMID 16698850 </ref><ref name="PMID19015413">Diagnosis and treatment of secondary (non-category 1) pulmonary hypertension. Circulation 118(21):2190-9 (2008) PMID 19015413 </ref><ref name="PMID19015412">Exercise-induced pulmonary arterial hypertension: a new addition to the spectrum of pulmonary vascular diseases. Circulation 118(21):2120-1 (2008) PMID 19015412 </ref><ref name="PMID18824655">Emerging concepts and translational priorities in pulmonary arterial hypertension. Circulation 118(14):1486-95 (2008) PMID 18824655 </ref><ref name="PMID18779455">Uncertainties in the diagnosis and treatment of pulmonary arterial hypertension. Circulation 118(11):1195-201 (2008) PMID 18779455 </ref><ref name="PMID17000921">Pulmonary arterial hypertension. Circulation 114(13):1417-31 (2006) PMID 17000921 </ref><ref name="PMID16636189">Chronic thromboembolic pulmonary hypertension. Circulation 113(16):2011-20 (2006) PMID 16636189 </ref><ref name="PMID19155250">A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J 30(4):394-403 (2009) PMID 19155250 </ref><ref name="PMID15589643">Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25(24):2243-78 (2004) PMID 15589643 </ref><ref name="PMID15657218">Pulmonary artery dissection: an emerging cardiovascular complication in surviving patients with chronic pulmonary hypertension. Heart 91(2):142-5 (2005) PMID 15657218 </ref><ref name="PMID11250981">Pulmonary arterial hypertension: new ideas and perspectives. Heart 85(4):475-80 (2001) PMID 11250981 </ref><ref name="PMID9538301">Pulmonary thromboendarterectomy. Heart 79(2):118-20 (1998) PMID 9538301 </ref></ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> </table>

Ossip Groth https://ddn.pluspedia.org/w/index.php?title=Pulmonale_Hypertonie&diff=43957&oldid=prev Ossip Groth am 15. April 2010 um 17:22 Uhr 2010-04-15T17:22:40Z

<p></p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="de"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Nächstältere Version</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Version vom 15. April 2010, 17:22 Uhr</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l2">Zeile 2:</td> <td colspan="2" class="diff-lineno">Zeile 2:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{| class="wikitable" |</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{| class="wikitable" |</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |<ref name="PMID11015616"><del style="font-weight: bold; text-decoration: none;">. et al., </del>Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. Physiol Rev 80(4):1337-72 (2000) PMID 11015616 </ref></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>| align="left" width="800" |<ref name="PMID11015616">Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. Physiol Rev 80(4):1337-72 (2000) PMID 11015616 </ref><ins style="font-weight: bold; text-decoration: none;"><ref name="PMID16103472">Evaluation and management of the patient with pulmonary arterial hypertension. Ann Intern Med 143(4):282-92 (2005) PMID 16103472 </ref><ref name="PMID18381346">The management of pulmonary hypertension in children. Arch Dis Child 93(7):620-5 (2008) PMID 18381346 </ref><ref name="PMID16320330">Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 52(12):3792-800 (2005) PMID 16320330 </ref><ref name="PMID12209501">Pulmonary hypertension in autoimmune rheumatic diseases: where are we now? Arthritis Rheum 46(8):1997-2009 (2002) PMID 12209501 </ref><ref name="PMID14180523">PRIMARY PULMONARY HYPERTENSION: A REVIEW, AND REPORT OF FIVE CASES. Can Med Assoc J 91():145-53 (1964) PMID 14180523 </ref><ref name="PMID19059957">Molecular mechanisms of pulmonary arterial hypertension: role of mutations in the bone morphogenetic protein type II receptor. Chest 134(6):1271-7 (2008) PMID 19059957 </ref><ref name="PMID18641107">ECG monitoring of treatment response in pulmonary arterial hypertension patients. Chest 134(6):1250-7 (2008) PMID 18641107 </ref><ref name="PMID18321898">Estimation of mean pulmonary artery pressure: simpler than expected. Chest 133(3):592-3 (2008) PMID 18321898 </ref><ref name="PMID15888866">Pulmonary arterial hypertension: the key role of echocardiography. Chest 127(5):1836-43 (2005) PMID 15888866 </ref><ref name="PMID15249495">Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126(1 Suppl):63S-71S (2004) PMID 15249495 </ref><ref name="PMID15249494">Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126(1 Suppl):35S-62S (2004) PMID 15249494 </ref><ref name="PMID15249493">Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126(1 Suppl):14S-34S (2004) PMID 15249493 </ref><ref name="PMID6365477">Pulmonary hypertensive diseases. Chest 85(3):397-405 (1984) PMID 6365477 </ref><ref name="PMID4810679">A problem in pulmonary hypertension. 2. The final course and autopsy findings. A clinicopathologic conference from the Division of Pulmonary Diseases, Hahnemann Medical College and Hospital, Philadelphia. Chest 65(2):192-7 (1974) PMID 4810679 </ref><ref name="PMID5099816">A reconsideration of the origins of pulmonary hypertension. Chest 59(1):82-94 (1971) PMID 5099816 </ref><ref name="PMID18614776">Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure? Clin J Am Soc Nephrol 3(5):1232-7 (2008) PMID 18614776 </ref><ref name="PMID18669790">Biomarkers in pulmonary hypertension. Eur Respir J 32(2):503-12 (2008) PMID 18669790 </ref><ref name="PMID18515559">Pulmonary hypertension in interstitial lung disease. Eur Respir J 31(6):1357-67 (2008) PMID 18515559 </ref><ref name="PMID18378784">Prostacyclin therapies for the treatment of pulmonary arterial hypertension. Eur Respir J 31(4):891-901 (2008) PMID 18378784 </ref><ref name="PMID18238950">Endothelin receptor antagonists in pulmonary arterial hypertension. Eur Respir J 31(2):407-15 (2008) PMID 18238950 </ref><ref name="PMID18238945">Pulmonary hypertension: basic concepts and practical management. Eur Respir J 31(2):236-7 (2008) PMID 18238945 </ref><ref name="PMID17074918">Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review. Eur Respir J 28(5):999-1004 (2006) PMID 17074918 </ref><ref name="PMID15802353">Noninvasive assessment and monitoring of the pulmonary circulation. Eur Respir J 25(4):758-66 (2005) PMID 15802353 </ref><ref name="PMID15083767">Chronic thromboembolic pulmonary hypertension. Eur Respir J 23(4):637-48 (2004) PMID 15083767 </ref><ref name="PMID12570125">Pulmonary arterial hypertension in children. Eur Respir J 21(1):155-76 (2003) PMID 12570125 </ref><ref name="PMID12503718">Pathobiology of pulmonary arterial hypertension. Eur Respir J 20(6):1559-72 (2002) PMID 12503718 </ref><ref name="PMID12449189">Haemodynamic evaluation of pulmonary hypertension. Eur Respir J 20(5):1314-31 (2002) PMID 12449189 </ref><ref name="PMID12412701">The new clinical trials on pharmacological treatment in pulmonary arterial hypertension. Eur Respir J 20(4):1037-49 (2002) PMID 12412701 </ref><ref name="PMID11936539">Pulmonary hypertension in collagen vascular disease. Eur Respir J 19(3):571-6 (2002) PMID 11936539 </ref><ref name="PMID10624750">Severe pulmonary hypertensive diseases: a perspective. Eur Respir J 14(6):1246-50 (1999) PMID 10624750 </ref><ref name="PMID8947091">Medical management of primary pulmonary hypertension. Eur Respir J 9(11):2401-9 (1996) PMID 8947091 </ref><ref name="PMID8666110">Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension. Eur Respir J 8(12):2129-38 (1995) PMID 8666110 </ref><ref name="PMID8575567">More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited. Eur Respir J 8(9):1445-9 (1995) PMID 8575567 </ref><ref name="PMID8143814">Medical treatment of pulmonary hypertension in chronic lung disease. Eur Respir J 7(1):148-52 (1994) PMID 8143814 </ref><ref name="PMID10801140">Diagnosis and treatment of pulmonary hypertension associated with collagen diseases. Intern Med 39(4):280-2 (2000) PMID 10801140 </ref><ref name="PMID14509142">Pulmonary arterial hypertension--the primary pulmonary hypertension syndromes. Isr Med Assoc J 5(4):298-303 (2003) PMID 14509142 </ref><ref name="PMID18596905">Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 118(7):2372-9 (2008) PMID 18596905 </ref><ref name="PMID19567712">Wide variation in clinicians' assessment of New York Heart Association/World Health Organization functional class in patients with pulmonary arterial hypertension. Mayo Clin Proc 84(7):586-92 (2009) PMID 19567712 </ref><ref name="PMID17352370">Pulmonary hypertension in patients with interstitial lung diseases. Mayo Clin Proc 82(3):342-50 (2007) PMID 17352370 </ref><ref name="PMID11484688">Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. N Engl J Med 345(5):319-24 (2001) PMID 11484688 </ref><ref name="PMID19825167">Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation. Respir Res 10():95 (2009) PMID 19825167 </ref><ref name="PMID17629802">Prognosis, screening, early detection and differentiation of arterial pulmonary hypertension. Swiss Med Wkly 137(23-24):331-6 (2007) PMID 17629802 </ref><ref name="PMID17370143">Update on therapies for pulmonary hypertension. Swiss Med Wkly 137(5-6):73-82 (2007) PMID 17370143 </ref><ref name="PMID16947087">Surgical treatment of chronic thromboembolic pulmonary hypertension. Swiss Med Wkly 136(31-32):491-7 (2006) PMID 16947087 </ref><ref name="PMID12644956">Pulmonary hypertension. Swiss Med Wkly 133(7-8):103-10 (2003) PMID 12644956 </ref><ref name="PMID10567632">Primary pulmonary hypertension. Thorax 54(12):1107-18 (1999) PMID 10567632 </ref><ref name="PMID18420094">Pulmonary arterial hypertension. J Am Coll Cardiol 51(16):1527-38 (2008) PMID 18420094 </ref><ref name="PMID15194183">Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):81S-88S (2004) PMID 15194183 </ref><ref name="PMID15194182">Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):73S-80S (2004) PMID 15194182 </ref><ref name="PMID15194181">Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):68S-72S (2004) PMID 15194181 </ref><ref name="PMID15194180">Endothelin receptor antagonists in pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):62S-67S (2004) PMID 15194180 </ref><ref name="PMID15194179">Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):56S-61S (2004) PMID 15194179 </ref><ref name="PMID15194178">End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives. J Am Coll Cardiol 43(12 Suppl S):48S-55S (2004) PMID 15194178 </ref><ref name="PMID15194177">Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):40S-47S (2004) PMID 15194177 </ref><ref name="PMID15194176">Genetic basis of pulmonary arterial hypertension: current understanding and future directions. J Am Coll Cardiol 43(12 Suppl S):33S-39S (2004) PMID 15194176 </ref><ref name="PMID15194175">Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 43(12 Suppl S):25S-32S (2004) PMID 15194175 </ref><ref name="PMID15194174">Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43(12 Suppl S):13S-24S (2004) PMID 15194174 </ref><ref name="PMID15194173">Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43(12 Suppl S):5S-12S (2004) PMID 15194173 </ref></ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div> </div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>|-</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>| bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''</div></td></tr> <tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l44">Zeile 44:</td> <td colspan="2" class="diff-lineno">Zeile 46:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Bibliographie ==</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>== Bibliographie ==</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div><references /></div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div><references /></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;"></ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">{{LinkWP_Miniartikel|Txt=Pulmonale Hypertonie|Link=Pulmonale Hypertonie}}</ins></div></td></tr> </table>

Ossip Groth https://ddn.pluspedia.org/w/index.php?title=Pulmonale_Hypertonie&diff=20970&oldid=prev Ossip Groth: Die Seite wurde neu angelegt: „Entstehender Artikel {| class="wikitable" | | bgcolor="#dfdfdf" | '''Freie Übersichtsartikel''' | align="left" width="800" |<re...“ 2010-01-08T17:35:07Z

<p>Die Seite wurde neu angelegt: „<a href="/wiki/Datei:Pptpdtjpg1.png" title="Datei:Pptpdtjpg1.png">miniatur|Entstehender Artikel</a> {| class="wikitable" | | bgcolor="#dfdfdf" | '''Freie Übersichtsartikel''' | align="left" width="800" |<re...“</p> <p><b>Neue Seite</b></p><div>[[Datei:pptpdtjpg1.png|miniatur|Entstehender Artikel]]<br /> {| class="wikitable" |<br /> | bgcolor="#dfdfdf" | '''Freie Übersichtsartikel'''<br /> | align="left" width="800" |<ref name="PMID11015616">. et al., Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. Physiol Rev 80(4):1337-72 (2000) PMID 11015616 </ref><br /> |-<br /> | bgcolor="#dfdfdf" | '''Wichtige Übersichtsartikel'''<br /> | align="left" width="800"| <br /> |-<br /> | bgcolor="#dfdfdf" | '''Medline Suchterm/ Synonyme'''<br /> | align="left" width="800"| <br /> |-<br /> | bgcolor="#00dfdf" | '''Was ist das'''<br /> | align="left" width="800"| <br /> |-<br /> | bgcolor="#dfdfdf" | '''Struktur'''<br /> | align="left" width="800"| <br /> |-<br /> | bgcolor="#dfdfdf" | '''Physiologie'''<br /> | align="left" width="800"| <br /> |-<br /> | bgcolor="#dfdfdf" | '''Knockout'''<br /> | align="left" width="800"| <br /> |-<br /> | bgcolor="#dfdfdf" | '''Transgen'''<br /> | align="left" width="800"| <br /> |-<br /> | bgcolor="#dfdfdf" | '''Mutation'''<br /> | align="left" width="800"| <br /> |-<br /> | bgcolor="#dfdfdf" | '''Polymorphismus'''<br /> | align="left" width="800"| <br /> |-<br /> | bgcolor="#dfdfdf" | '''Genexpression'''<br /> | align="left" width="800"| <br /> |-<br /> | bgcolor="#dfdfdf" | '''Inhibitoren'''<br /> | align="left" width="800"| <br /> |-<br /> | bgcolor="#dfdfdf" | '''Agonisten'''<br /> | align="left" width="800"| <br /> |}<br /> <br /> <br /> == Bibliographie ==<br /> <references /></div>

Ossip Groth